延边医学
延邊醫學
연변의학
YAN BIAN YI XUE
2014年
18期
39-40
,共2页
恩替卡韦%乙型肝炎%抗痨%结核
恩替卡韋%乙型肝炎%抗癆%結覈
은체잡위%을형간염%항로%결핵
entecavir%hepatitis B%anti tuberculosis therapy%tuberculosis
目的：：探讨临床中结核病合并乙型肝炎患者应用恩替卡韦抗病毒的临床状况。[方法]回顾分析从2008年10月-2013年10月五年间我院确诊结核病合并存在乙型肝炎324例患者,在抗痨同时应用恩替卡韦抗病毒的的临床状况。结论324例患者中,212例应用恩替卡韦抗乙型肝炎病毒后,乙肝病毒在抗痨期间能良好抑制，肝损害与非肝病患者比例接近。
目的：：探討臨床中結覈病閤併乙型肝炎患者應用恩替卡韋抗病毒的臨床狀況。[方法]迴顧分析從2008年10月-2013年10月五年間我院確診結覈病閤併存在乙型肝炎324例患者,在抗癆同時應用恩替卡韋抗病毒的的臨床狀況。結論324例患者中,212例應用恩替卡韋抗乙型肝炎病毒後,乙肝病毒在抗癆期間能良好抑製，肝損害與非肝病患者比例接近。
목적：：탐토림상중결핵병합병을형간염환자응용은체잡위항병독적림상상황。[방법]회고분석종2008년10월-2013년10월오년간아원학진결핵병합병존재을형간염324례환자,재항로동시응용은체잡위항병독적적림상상황。결론324례환자중,212례응용은체잡위항을형간염병독후,을간병독재항로기간능량호억제，간손해여비간병환자비례접근。
Aim: To explore the clinical status of entecavir us-age in patients with tuberculosis and hepatitis B. Method: A retro-spective analysis of patients with tuberculosis and hepatitis B, who took entecavir and anti tuberculosis therapy at the same time in our hospital from October 2008 to October 2013 was made. Re-sult: 324 patients were enrolled. 212 of them had good response during the anti tuberculosis therapy and few liver injury similar to patients without liver disease.
